| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |